Упрощенная HTML-версия
164
187. Эффект многократного перорального введения карминомицина на
животных / Л.Е. Гольдберг [и др.] // Антибиотики. -1978.-Т.23, №7. -С. 611-617.
188. Юлдашев А.Ю. Закономерности развития и становление иммунной
системы слизистой оболочки тонкой кишки / А.Ю. Юлдашев, З.А. Кахаров,
М.А. Юлдашев // Морфология. - 2008. - Т. 134, № 6. - С. 42-45.
189.
26-year-old patient with ulcerative colitis and anemia / F. Kreth [et al.] //
Internist (Berl). – 2004. – Vol. 45, № 2. – P. 217-220.
190. A phase I trial of the novel proteasome inhibitor PS341 in advanced solid
tumour malignancies / C. Aghajanian [et al.] // Clin. Cancer Res. – 2002. – Vol. 8, №
8. – P. 2505-2511.
191. A phase II study of epirubicin, cisplatin and raltitrexed combination
chemotherapy (ECT) in patients with advanced oesophageal and gastric
adenocarcinoma / H.J. Mackay [et al.] // Ann. Oncol. – 2001. – Vol. 12, № 10. – P.
1407-1410.
192. A phase II study of sequential chemotherapy with docetaxel after the
weekly PELF regimen in advanced gastric cancer. A report from the Italian group for
the study of digestive tract cancer / S. Cascinu [et al.] // Br.J. Cancer. – 2001. – Vol.
84, № 4. – P. 470-474.
193. A pilot clinical trial of postoperative intensive weekly chemotherapy using
cisplatin, epi-doxorubicin, 5-fluorouracil, 6S-leucovorin, glutathione and filgrastim in
patients with resected gastric cancer / F. Graziano [et al.] // Tumori. – 1998. – Vol.84,
№ 3. – P. 368-371.
194. A rapid and simple method for measuring thymocyte apoptosis by
propidium iodide staining and flow cytometry / I. Nicoletti [et al.] // J. Immunol.
Methods. – 1991. – Vol. 139, № 2. – P. 271-279.
195. A transmembrane chemokine, CXC chemokine ligand 16, expressed by
lymph node fibroblastic reticular cells has the potential to regulate T cell migration
and adhesion / Т. Наrа [et al.] // Int. Immunol. – 2006. – Vol. 18, № 2. – P. 301-311.
196. Adams J. Proteasome inhibition: a new strategy in cancer treatment / J.
Adams, V. Palombella, P. Elliott // Invest. New Drugs.–2000.-Vol.18, №2.–P.109-121.